MALT lymphoma localizations according to the stage of the disease
| . | All Patients . | Stage I-II E . | Stage III-IV . | |||
|---|---|---|---|---|---|---|
| n . | (%) . | n . | (%) . | n . | (%) . | |
| Total | 158 | (100) | 104 | (100) | 54 | (100) |
| One MALT-organ localization | 140 | (89) | 103 | (99) | 37 | (70) |
| GI tract | ||||||
| Stomach | 52 | (33) | 46 | (44) | 6 | (13) |
| Intestinal tract | 12 | (8.5) | 8 | (8) | 4 | (7) |
| Non-GI tract | ||||||
| Lung | 15 | (9.5) | 8 | (8) | 7 | (13) |
| Breast | 5 | (3) | 3 | (3) | 2 | (4) |
| Orbit | 16 | (10) | 12 | (11) | 4 | (7) |
| Head and neck | 18 | (11) | 13 | (12) | 5 | (9) |
| Thyroid | 6 | (4) | 6 | (6) | 0 | — |
| Skin | 16 | (10) | 7 | (7) | 9 | (17) |
| Multiple MALT-organ localizations | 18 | (11) | 1 | (1) | 17 | (30) |
| GI tract | ||||||
| Stomach + intestinal tract | 7 | (3.5) | 1 | (1) | 6 | (10) |
| Non-GI tract | ||||||
| Lung + orbit | 1 | (0.75) | 0 | — | 1 | (2) |
| Lung + skin | 1 | (0.75) | 0 | — | 1 | (2) |
| Orbit + head/neck | 1 | (0.75) | 0 | — | 1 | (2) |
| Orbit + head/neck + breast | 1 | (0.75) | 0 | — | 1 | (2) |
| GI tract + non-GI tract | ||||||
| GI tract + lung | 5 | (3) | 0 | — | 5 | (10) |
| Stomach + head/neck | 2 | (1.5) | 0 | — | 2 | (04) |
| . | All Patients . | Stage I-II E . | Stage III-IV . | |||
|---|---|---|---|---|---|---|
| n . | (%) . | n . | (%) . | n . | (%) . | |
| Total | 158 | (100) | 104 | (100) | 54 | (100) |
| One MALT-organ localization | 140 | (89) | 103 | (99) | 37 | (70) |
| GI tract | ||||||
| Stomach | 52 | (33) | 46 | (44) | 6 | (13) |
| Intestinal tract | 12 | (8.5) | 8 | (8) | 4 | (7) |
| Non-GI tract | ||||||
| Lung | 15 | (9.5) | 8 | (8) | 7 | (13) |
| Breast | 5 | (3) | 3 | (3) | 2 | (4) |
| Orbit | 16 | (10) | 12 | (11) | 4 | (7) |
| Head and neck | 18 | (11) | 13 | (12) | 5 | (9) |
| Thyroid | 6 | (4) | 6 | (6) | 0 | — |
| Skin | 16 | (10) | 7 | (7) | 9 | (17) |
| Multiple MALT-organ localizations | 18 | (11) | 1 | (1) | 17 | (30) |
| GI tract | ||||||
| Stomach + intestinal tract | 7 | (3.5) | 1 | (1) | 6 | (10) |
| Non-GI tract | ||||||
| Lung + orbit | 1 | (0.75) | 0 | — | 1 | (2) |
| Lung + skin | 1 | (0.75) | 0 | — | 1 | (2) |
| Orbit + head/neck | 1 | (0.75) | 0 | — | 1 | (2) |
| Orbit + head/neck + breast | 1 | (0.75) | 0 | — | 1 | (2) |
| GI tract + non-GI tract | ||||||
| GI tract + lung | 5 | (3) | 0 | — | 5 | (10) |
| Stomach + head/neck | 2 | (1.5) | 0 | — | 2 | (04) |